DAVE vs. LLY
DAVE (Dave Inc.) and LLY (Eli Lilly and Company) are both stocks. DAVE operates in Software - Application (Technology), while LLY operates in Drug Manufacturers - General (Healthcare). Over the past 5 years, DAVE returned -0.45%/yr vs 39.70%/yr for LLY. At a 0.05 correlation, their price movements are largely independent.
Performance
DAVE vs. LLY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DAVE achieves a 39.89% return, which is significantly higher than LLY's 2.90% return.
DAVE
- 1D
- -1.50%
- 1M
- 35.57%
- YTD
- 39.89%
- 6M
- 42.07%
- 1Y
- 46.79%
- 3Y*
- 297.53%
- 5Y*
- -0.45%
- 10Y*
- —
LLY
- 1D
- 0.32%
- 1M
- 3.48%
- YTD
- 2.90%
- 6M
- 2.73%
- 1Y
- 45.51%
- 3Y*
- 34.88%
- 5Y*
- 39.70%
- 10Y*
- 33.08%
DAVE vs. LLY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
DAVE Dave Inc. | 39.89% | 154.73% | 936.61% | -9.64% | -97.17% | 4.59% |
LLY Eli Lilly and Company | 2.90% | 40.25% | 33.30% | 60.91% | 34.26% | 47.97% |
Correlation
The correlation between DAVE and LLY is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.07 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.05 |
Correlation (All Time) Calculated using the full available price history since Apr 26, 2021 | 0.05 |
Fundamentals
DAVE:
$4.46B
LLY:
$987.35B
DAVE:
$15.54
LLY:
$28.14
DAVE:
19.93
LLY:
39.16
DAVE:
0.09
LLY:
0.79
DAVE:
8.13
LLY:
13.70
DAVE:
21.89
LLY:
31.65
DAVE:
$551.52M
LLY:
$72.25B
DAVE:
$427.68M
LLY:
$59.75B
DAVE:
$165.95M
LLY:
$32.97B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DAVE vs. LLY — Risk / Return Rank
DAVE
LLY
DAVE vs. LLY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Dave Inc. (DAVE) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DAVE | LLY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.57 | ||
| Sortino ratioReturn per unit of downside risk | -0.47 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.24 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | 1.05 | 1.97 | -0.92 |
| Martin ratioReturn relative to average drawdown | 1.89 | 4.93 | -3.04 |
Loading charts...
Drawdowns
DAVE vs. LLY - Drawdown Comparison
The maximum DAVE drawdown since its inception was -99.01%, which is greater than LLY's maximum drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for DAVE and LLY.
Loading charts...
Drawdown Indicators
| DAVE | LLY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.01% | -68.24% | -30.77% |
Max Drawdown (1Y)Largest decline over 1 year | -44.67% | -23.18% | -21.49% |
Max Drawdown (3Y)Largest decline over 3 years | -44.67% | -34.48% | -10.19% |
Max Drawdown (5Y)Largest decline over 5 years | -99.01% | -34.48% | -64.53% |
Max Drawdown (10Y)Largest decline over 10 years | — | -34.48% | — |
Current DrawdownCurrent decline from peak | -32.32% | -5.07% | -27.25% |
Average DrawdownAverage peak-to-trough decline | -68.78% | -19.20% | -49.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.86% | 9.26% | +15.60% |
Volatility
DAVE vs. LLY - Volatility Comparison
Dave Inc. (DAVE) has a higher volatility of 22.49% compared to Eli Lilly and Company (LLY) at 8.76%. This indicates that DAVE's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DAVE | LLY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.49% | 8.76% | +13.73% |
Volatility (6M)Calculated over the trailing 6-month period | 50.17% | 26.89% | +23.28% |
Volatility (1Y)Calculated over the trailing 1-year period | 73.73% | 37.90% | +35.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 98.71% | 32.46% | +66.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 97.16% | 30.20% | +66.96% |
Dividends
DAVE vs. LLY - Dividend Comparison
DAVE has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.59%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DAVE Dave Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LLY Eli Lilly and Company | 0.59% | 0.56% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% |
Financials
DAVE vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between Dave Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DAVE vs. LLY - Profitability Comparison
DAVE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dave Inc. reported a gross profit of 120.00M and revenue of 147.59M. Therefore, the gross margin over that period was 81.3%.
LLY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.
DAVE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dave Inc. reported an operating income of 21.15M and revenue of 147.59M, resulting in an operating margin of 14.3%.
LLY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.
DAVE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dave Inc. reported a net income of 57.94M and revenue of 147.59M, resulting in a net margin of 39.3%.
LLY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.
Frequently Asked Questions
DAVE and LLY have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DAVE has higher volatility (22.49%) compared to LLY (8.76%). In terms of maximum drawdown, DAVE dropped -99.01% vs LLY's -68.24%.
LLY currently has the higher Sharpe Ratio (1.21 vs 0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DAVE and LLY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer